Brief: Myriad Genetics Q3 Operating Income USD -20 Million
07/11/2024 21:05
Nov 07 (Reuters) - Myriad Genetics Q3 operating expenses USD 169.8 million. * Q3 adjusted operating expenses USD 141 million * Q3 adjusted operating income USD 9.5 million * Q3 gross margin 70.2%
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple